• Kit Solutions

    Kit Solutions

    AntBio offers mIHC kits, organoid culture kits, conventional and One-step ELISA assay kits, RNA/DNA/protein interaction kits, etc.

  • Cytokine Solutions

    Cytokine Solutions

    AntBio provides related cytokines of different cell types (organoids, stem cells, immune cells, etc.) with high purity and high activity verification

  • Target Protein Solutions

    Target Protein Solutions

    AntBio offers high performance target proteins in different research areas (antibody drugs, ADC drugs, CAR-T, small molecule drugs, etc.)

  • Loading Control

    Loading Control

    AntBio offers reliable and high-quality loading control antibodies, essential for accurate normalization in Western blotting and other protein quantification assays.

Essential Cytokines Special Offer

Cytokines as low as $29

15 Jul – 31 Aug, 2026

View Promotions

20% off for 5+ items

Enjoy 20% discount on 5 or more items storewide including OneStep ELISA Kits, mIHC Kits, IHC antibodies, Organoid Culture Kits, PTMs antibodies and so on.

Promo Period: 1 July 2026 to 31 Dec 2026

View Promotions

New Semester Launch | Spacial Biology

Discount Code: ANT2608@20

Promotion valid from 15 Aug to 31 Oct, 2026

View Promotions
bg

About Us

AntBio - Fueling Research, Feeding Discovery

AntBio is a biotechnology group company dedicated to serving life sciences, aiming to help scientists accelerate research and improve work efficiency. AntBio provides comprehensive and high-quality reagent tools for basic research, drug development, and diagnosis, including research grade antibodies, proteins, biochemical reagents, and assay kits. These research tools are widely used in different segments of life science research. The group company currently consists of three brands, Absin, Starter-Bio and UA-Bio.

About Us

50k

Happy Clients

100k

Products

70+

Doctor/Expert

20,000+

Publications

IHC Antibody Raw Materials: Core Reagents Bridging Antibody Screening to Tissue‑Based Basic Research

IHC Antibody Raw Materials:...

Gain insights into IHC antibody raw materials for basic tissue‑based research, covering polyclonal, monoclonal and recombinant antibody features, multi‑step antibody validation workflows including CRISPR knockout verification, FFPE tissue assay optimization,...

IHC Antibody Raw Materials:...

Gain insights into IHC antibody raw materials for basic tissue‑based research, covering polyclonal, monoclonal and recombinant antibody features, multi‑step antibody...

View Details
MMAE and MMAF: Widely Studied Cytotoxic Payloads for Antibody‑Drug Conjugate Basic Research

MMAE and MMAF: Widely Studied Cytotox...

Explore basic ADC payload research covering monomethyl auristatin E (MMAE) and monomethyl auristatin F (MMAF), including tubulin‑inhibiting mechanisms, linker‑payload pairing strategies, bystander‑effect profiles, and in‑vitro assay workflows for antibody‑drug conjugate...

MMAE and MMAF: Widely Studied Cytotox...

Explore basic ADC payload research covering monomethyl auristatin E (MMAE) and monomethyl auristatin F (MMAF), including tubulin‑inhibiting mechanisms, linker‑payload pairing...

View Details
Optimizing Research Strategies for Mesothelin‑Targeted Antibody Reagents in Basic Tumor Biology Studies

Optimizing Research Strategies for Me...

Explore mesothelin (MSLN) basic research including GPI‑anchored protein biology, downstream Akt‑ERK‑JNK signaling, and challenges for mesothelin antibody reagent development. This article covers research strategies for mesothelin epitope selection, soluble mesothelin...

Optimizing Research Strategies for Me...

Explore mesothelin (MSLN) basic research including GPI‑anchored protein biology, downstream Akt‑ERK‑JNK signaling, and challenges for mesothelin antibody reagent development. This...

View Details
EGFR‑Targeted Monoclonal Antibodies: Mechanisms, Multi‑Layered Resistance and Mutation‑Detection in Solid‑Tumour Basic‑Research

EGFR‑Targeted Monoclonal Antibodies: ...

This article dissects EGFR‑targeted monoclonal‑antibody mechanism, multi‑layered drug‑resistance patterns and mutation‑detection workflows in solid‑tumour basic‑research. It covers extracellular‑domain mutation‑driven resistance, bypass‑kinase activation, tumour‑microenvironment influences and IHC‑based EGFR delE746‑A750 mutation‑profiling approaches....

EGFR‑Targeted Monoclonal Antibodies: ...

This article dissects EGFR‑targeted monoclonal‑antibody mechanism, multi‑layered drug‑resistance patterns and mutation‑detection workflows in solid‑tumour basic‑research. It covers extracellular‑domain mutation‑driven resistance,...

View Details